Vanda Pharmaceuticals
VNDA
NZ$7.85
Share price
-0.43%
Change (1 day)
-22.76%
Change (1 year)
Categories
Vanda Pharmaceuticals (VNDA) - Total assets
Total assets on the balance sheet as of March 2025 : NZ$1.06 Billion
According to Vanda Pharmaceuticals's latest financial reports the company's total assets are NZ$1.06 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Vanda Pharmaceuticals - Total assets on balance sheet (from 2005 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | NZ$1.16 B | 13.48% |
| 2023-12-31 | NZ$1.02 B | 2.64% |
| 2022-12-31 | NZ$0.99 B | 14.91% |
| 2021-12-31 | NZ$0.86 B | 17.58% |
| 2020-12-31 | NZ$0.73 B | 2.93% |
| 2019-12-31 | NZ$0.71 B | 45.06% |
| 2018-12-31 | NZ$0.49 B | 71.18% |
| 2017-12-31 | NZ$0.28 B | -4.76% |
| 2016-12-31 | NZ$0.30 B | -2.44% |
| 2015-12-31 | NZ$0.31 B | 42.05% |
| 2014-12-31 | NZ$0.21 B | 25.63% |
| 2013-12-31 | NZ$0.17 B | 5.95% |
| 2012-12-31 | NZ$0.16 B | -29.63% |
| 2011-12-31 | NZ$0.23 B | -15.29% |
| 2010-12-31 | NZ$0.27 B | -11.12% |
| 2009-12-31 | NZ$0.31 B | 261.16% |
| 2008-12-31 | NZ$86.04 M | -31.95% |
| 2007-12-31 | NZ$0.12 B | 145.68% |
| 2006-12-31 | NZ$51.46 M | -1.6% |
| 2005-12-31 | NZ$52.3 M | 110.25% |
| 2004-12-31 | NZ$24.87 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | NZ$167.69 B | 15,715.05% | 🇨🇭 Switzerland |
 Eli Lilly LLY | NZ$149.98 B | 14,045.23% | 🇺🇸 USA |
 Johnson & Johnson JNJ | NZ$324.96 B | 30,547.25% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | NZ$155.08 B | 14,526.01% | 🇺🇸 USA |
 Pfizer PFE | NZ$349.05 B | 32,819.16% | 🇺🇸 USA |
 Titan Pharmaceuticals
TTNP | NZ$3.61 M | -99.66% | 🇺🇸 USA |
 Merck MRK | NZ$193.16 B | 18,117.35% | 🇺🇸 USA |